A Novel Patent Ductus Arteriosus Severity Score to Predict Clinical Outcomes in Premature Neonates.

ABSTRACT: Background: Patent Ductus Arteriosus (PDA) in premature neonates has been associated with comorbidities including chronic lung disease (CLD), and death. However, the treatment of PDA remains controversial. There have been several echocardiographic variables previously used to determine the hemodynamic significance of PDA but their utility in early prediction of clinical outcomes is not well studied. Objective: The objective of our study was to evaluate the use of a severity scoring system incorporating markers of systemic under perfusion, pulmonary over perfusion and left ventricular (LV) function in predicting clinical outcomes in premature neonates. Methods: It is a single center prospective observational study involving newborns < 32 weeks' gestation. An echocard

SUBMITTER: Umapathi KK 

PROVIDER: S-EPMC9033137 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature